CRISPR Therapeutics News - CRSP

Company Name	Stock Ticker Symbol	Market	Type
CRISPR Therapeutics AG	CRSP	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.5236	0.97%	54.2536	11:04:38

Open Price	Low Price	High Price	Close Price	Prev Close
54.21	52.814	54.935		53.73

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	16:30	GLOBE	CRISPR Therapeutics to Present Oral Presentation at the..
4/03/2024	08:00	GLOBE	CRISPR Therapeutics to Present at the Annual Needham Virtual..
4/01/2024	08:00	GLOBE	CRISPR Therapeutics to Present at the American Society of..
3/13/2024	08:30	GLOBE	CRISPR Therapeutics Proposes New Appointment to the Board of..
2/21/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/21/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/21/2024	07:50	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/21/2024	07:45	EDGAR2	Form 8-K - Current report
2/21/2024	07:30	GLOBE	CRISPR Therapeutics Provides Business Update and Reports..
2/16/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/15/2024	16:30	EDGAR2	Form 144 - Report of proposed sale of securities
2/15/2024	08:30	GLOBE	CRISPR Therapeutics to Present at the Citi 2024 Virtual..
2/13/2024	08:44	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/13/2024	08:30	GLOBE	CRISPR Therapeutics Announces $280 Million Registered Direct..
2/13/2024	06:30	EDGAR2	Form 8-K - Current report
2/13/2024	02:30	GLOBE	European Commission Approves First CRISPR/Cas9 Gene-Edited..
1/31/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/29/2024	16:08	EDGAR2	Form 144 - Report of proposed sale of securities
1/29/2024	16:00	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/18/2024	17:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/16/2024	17:00	EDGAR2	Form 144 - Report of proposed sale of securities
1/16/2024	16:11	EDGAR2	Form 8-K - Current report
1/16/2024	16:01	GLOBE	CRISPR Therapeutics Announces U.S. Food and Drug..
1/10/2024	11:36	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/08/2024	07:00	GLOBE	CRISPR Therapeutics Highlights Strategic Priorities and 2024..
1/03/2024	08:30	GLOBE	CRISPR Therapeutics to Present at the 42nd Annual J.P...
12/19/2023	16:23	EDGAR2	Form 8-K - Current report
12/15/2023	08:58	EDGAR2	Form 8-K - Current report
12/13/2023	09:22	EDGAR2	Form 8-K - Current report
12/08/2023	16:11	DJN	Bluebird Bio Shares Slide 41% on Black-Box Label, Higher..
12/08/2023	13:16	EDGAR2	Form 8-K - Current report
12/08/2023	12:52	BW	Vertex and CRISPR Therapeutics Announce US FDA Approval of..
12/08/2023	11:46	DJN	CRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in..
12/04/2023	16:26	EDGAR2	Form 8-K - Current report
12/04/2023	16:15	GLOBE	CRISPR Therapeutics Announces Updates to Immuno-Oncology..
11/16/2023	07:21	EDGAR2	Form 8-K - Current report
11/16/2023	01:45	BW	Vertex and CRISPR Therapeutics Announce Authorization of..
11/06/2023	16:42	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/2023	16:33	EDGAR2	Form 8-K - Current report
11/06/2023	16:15	GLOBE	CRISPR Therapeutics Provides Business Update and Reports..
11/06/2023	05:01	GLOBE	CRISPR Therapeutics Announces Preclinical Data at the..
11/01/2023	06:29	DJN	Crispr Therapeutics Shares Rally Premarket After Favorable..
10/31/2023	17:53	GLOBE	CRISPR Therapeutics Announces Completion of FDA Advisory..
10/31/2023	07:05	GLOBE	CRISPR Therapeutics Trading Halted Today; FDA Advisory..
10/17/2023	17:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/17/2023	17:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/17/2023	17:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/17/2023	17:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/16/2023	08:00	GLOBE	CRISPR Therapeutics Proposes New Appointment to the Board of..
9/27/2023	09:01	GLOBE	CRISPR Therapeutics to Present at the Society for..